Randomized Study of Obicetrapib in Combination With Ezetimibe

Clinical trial NCT04770389 · COMPLETED

Trial details

NCT number: NCT04770389
Sponsor: NewAmsterdam Pharma
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Dyslipidemias High Cholesterol Hypercholesterolemia

Start date: 2021-02-23
Primary completion: 2021-05-07
Enrollment: 112

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.